Cargando…
Successful Drug Desensitization to Ustekinumab in a Patient with Crohn's Disease
Ustekinumab is a monoclonal antibody used as treatment for various inflammatory conditions. We present a pediatric patient with Crohn's disease who did not tolerate infliximab and was then changed to ustekinumab. He developed anaphylaxis to the medication after the second dose. A drug desensiti...
Autores principales: | Cohen, Barrie, Tomer, Gitit, Gavrilova, Tatyana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458924/ https://www.ncbi.nlm.nih.gov/pubmed/34720823 http://dx.doi.org/10.1159/000516318 |
Ejemplares similares
-
Pustular Rash in Crohn's Patient on Ustekinumab Raises Concern for Drug-Induced Paradoxical Psoriasis
por: Barahimi, Mitra, et al.
Publicado: (2021) -
Ustekinumab for Successful Treatment of Refractory Esophageal Crohn’s Disease
por: Barkin, Jodie A., et al.
Publicado: (2016) -
Isolated Bilateral Gastrocnemius Myositis in Crohn Disease Successfully Treated with Adalimumab
por: Vadala di Prampero, Salvatore, et al.
Publicado: (2016) -
Successful Treatment of Oral Crohn’s Disease by Ustekinumab
por: Jukema, Jelmer B, et al.
Publicado: (2020) -
Delayed Diagnosis of Vulvar Crohn's Disease in a Patient with No Gastrointestinal Symptoms
por: Wells, Leah Ellis, et al.
Publicado: (2018)